NCT01601028View on ClinicalTrials.gov

Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Autoimmune DiseasesSjogren's SyndromeDry Eye
Interventions
DRUG

Hydroxychloroquine

Hydroxychloroquine 300 mg once daily p.o. for 12 weeks and go off medication for 4 weeks (total 16 weeks)

DRUG

Placebo

2cp/day for 12 weeks and go off medication for 4 weeks (total 16 weeks)

Trial Locations (1)

110-744

Seoul National Unversity Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01601028 - Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome | Biotech Hunter | Biotech Hunter